CareCloud (CCLD) Q3 2026 earnings review

CareCloud profit hits a record, but fourth-quarter sales look lower

CareCloud, which sells software and billing services to medical practices and hospitals, delivered record profit even as its sales growth slowed. Third-quarter revenue rose 9% from a year ago, while operating margin nearly doubled to 20% on lower service delivery costs and reduced research expenses. Chief executive Stephen Snyder kept the full-year outlook unchanged, which by our math points to fourth-quarter revenue falling about 4%.

At a glance
Revenue$33.7M +8.6% from a year ago
Operating margin19.5% 10.3% a year ago
Free cash flow$3.8M -33% from a year ago
Full-year outlookUnchanged implies -4% Q4 sales by our math

โš–๏ธ Verdict: ๐ŸŸข Bullish

The story got better because the third-quarter margin jump put the full-year profit target within reach and the company appointed a permanent finance chief. CareCloud also booked its first enterprise AI sales and used cash to pay down $12 million of bank debt. One caution: the new bank loans plus remaining preferred dividends cost $2.3 million this quarter, more than the preferred dividends alone cost a year ago, and free cash flow fell.

The question now is whether AI and compliance tools can grow fast enough to replace shrinking legacy software once the Medsphere acquisition boost fades next quarter. Either new products lift total sales, or fourth-quarter revenue drops as the full-year plan implies. The pro forma revenue table in the upcoming quarterly filing and fourth-quarter sales will tell.

๐Ÿ‚ Bull Case

๐ŸŸข๐ŸŸข fading MARGIN

Cost Cuts Delivered the Second-Half Profit Step-Up

CareCloud sells software and billing services, known as revenue cycle management (RCM), to doctors and hospitals. Its full-year plan needed a big second-half profit jump, and third-quarter operating profit more than doubled from a year ago to $6.6 million. The healthcare technology company also named Bonnie Boyer as permanent finance chief, ending a year under an interim leader.

Chief strategy officer A. Hadi Chaudhry said artificial intelligence (AI) and automation "cut manual claim touches by 44% in just three months, so our teams handle more volume with the same headcount". CareCloud also cited "a shift toward higher-margin offerings and a more efficient core business".

  • Direct operating costs (cost of delivering services): 49.5% of revenue, down 2.7 percentage points from a year ago
  • Research and development: 3.1% of revenue, down 2.0 percentage points from a year ago, and cut in half from last quarter as CareCloud shifted $0.7 million more software work to the balance sheet
  • Depreciation and amortization: 9.4% of revenue, down 3.6 percentage points from a year ago

What to watch: fourth-quarter operating profit, which needs to keep this margin on lower implied sales to reach the full-year profit target.

๐ŸŸข strengthening PRODUCT

AI and Compliance Booked Early Wins

CareCloud has spent the past year building AI tools and buying smaller firms like Empower, a healthcare compliance business acquired in May 2026. Investors have waited to see whether those moves bring in new customers and sales.

This quarter brought the first proof. Speaking of enterprise client LailaCare, Chaudhry said "we are building AI-enabled workflows for enterprise clients, and we recognized our first revenue from that work this quarter". Meanwhile, Empower overturned more than $1 million in disputed insurance claims for a client and helped CareCloud sign new billing contracts with a medical management group and a wound-care practice.

CareCloud also named Empower founder Mitchell Brie as chief compliance officer to sell compliance services across its network of 40,000 healthcare providers. What to watch: the launch of the subscription compliance software planned for late in the fourth quarter, which will test whether existing doctors buy the extra service.

๐Ÿป Bear Case

๐Ÿ”ด๐Ÿ”ด persistent GROWTH

The Outlook Points to Shrinking Fourth-Quarter Sales

CareCloud bought hospital software maker Medsphere in August 2025, which boosted reported sales growth over the past year. Chief executive Stephen Snyder kept the full-year revenue outlook at $128 million to $132 million because of the third-quarter profit record.

Because the็ฌฌไธ‰-quarter comparison included only five weeks of Medsphere, reported revenue growth slowed from 16.4% last quarter to 8.6% this quarter. The fourth quarter will compare against the first full quarter of Medsphere ownership, removing the acquisition boost.

By our math, the middle of the full-year outlook leaves $33.1 million of revenue for the fourth quarter, down 3.8% from $34.4 million a year ago. Even the top of the full-year range implies only 2.0% growth. That shows the combined business has not yet returned to meaningful growth from businesses owned a year ago.

What to watch: the pro forma revenue table in the upcoming quarterly filing, which will show whether underlying sales shrank as fast as last quarter's 11.4% drop.

๐Ÿ”ด๐Ÿ”ด persistent CAPITAL ALLOCATION contradicts narrative

The Debt Swap Costs More Than the Dividends It Replaced

"Record earnings and a simpler capital structure are working together for common shareholders," finance chief Bonnie Boyer said. In May 2026, CareCloud borrowed nearly $49 million from banks to buy back all of its Series B preferred stock, aiming to replace preferred dividends with cheaper bank debt.

In the first full quarter after the deal, the new loans cost more than the dividends they replaced. Net interest expense jumped to $1.7 million from $0.1 million a year ago, while remaining Series A preferred dividends were $0.5 million. Together, interest and preferred dividends took $2.3 million in the third quarter, up from $1.4 million a year ago by our math.

CareCloud repaid its $9.0 million credit line and cut total debt by $11.7 million from last quarter to $37.3 million. Because $10.6 million of that debt comes due within a year, current liabilities now exceed current assets by $4.2 million. What to watch: fourth-quarter interest expense and cash levels as monthly loan payments continue.

๐Ÿ”ด persistent DISCLOSURE

Risks this quarter didn't answer

Several standing concerns around revenue quality, legal exposure, and governance received no new numbers in the earnings release and await the quarterly filing.

  • AI and project sales: CareCloud gave no dollar figure for AI revenue or its shrinking medSR hospital consulting business; the filing's revenue breakdown will show both.
  • Executive warrant and related parties: the filing will show the accounting cost of the 4.3 million share warrant granted to the executive chairman in July.
  • Cybersecurity lawsuit and offshore staff: the filing's legal notes will update the class-action lawsuit from the March data breach and cash held in Pakistan and Sri Lanka.

๐Ÿ’ฒ Other KPIs

Free cash flow (26Q3) $3.79 million
โ‡˜ decelerating

Free cash flow โ€” operating cash flow minus equipment purchases and software development โ€” fell 33.2% from a year ago and dropped from $5.75 million last quarter. Profit rose, but unpaid customer bills (accounts receivable) climbed $2.41 million in the quarter to $16.53 million, and CareCloud capitalized $1.53 million of software costs, nearly double the prior quarter.

Total deferred revenue (26Q3) $4.97 million
โ‡˜ decelerating

Deferred revenue โ€” cash customers have paid upfront for software and services not yet delivered โ€” fell 8.7% from last quarter ($5.44 million) and dipped 0.6% from a year ago by our math. It has shrunk for two straight quarters, showing that upfront customer bookings are not building a larger backlog for future quarters.

๐Ÿ”ฎ Guidance

FY26 Revenue $128โ€“132 million
๐Ÿ † unchanged from $128โ€“132 million
โ‡˜ decelerating

Unchanged. The plan still calls for 7.9% growth at the middle of the range for the full year. By our math, subtracting nine-month sales of $96.9 million leaves $31.1 million to $35.1 million for the fourth quarter, or $33.1 million at the middle โ€” down 3.8% from a year ago and down 1.8% from the third quarter as the Medsphere acquisition laps.

FY26 Adjusted EBITDA $29โ€“31 million
๐Ÿ † unchanged from $29โ€“31 million
โ‡˜ decelerating

Unchanged. The full-year target still points to 8.9% growth at the middle of the range over 2025's $27.5 million. After $21.2 million in the first nine months, the outlook leaves $7.8 million to $9.8 million for the fourth quarter by our math ($8.8 million at the middle, or a 26.6% margin), making the annual goal achievable after the third-quarter jump.

FY26 Net income per share $0.20โ€“0.23
๐Ÿ † unchanged from $0.20โ€“0.23
โ‡— accelerating

Unchanged. The outlook still calls for profit per share to more than double from $0.10 in 2025. With $0.09 earned in the first nine months after a $0.10 third quarter, the full-year plan leaves $0.11 to $0.14 for the fourth quarter by our math ($0.125 at the middle), up from $0.04 in the fourth quarter of last year.

โ“ Key Questions

Did underlying sales stop shrinking in the third quarter?

Pro forma revenue โ€” which includes Medsphere in both periods โ€” fell 11.4% in the second quarter, and the full-year outlook implies a 3.8% fourth-quarter revenue drop. Investors need the third-quarter pro forma figure from the quarterly filing to see if customer losses slowed.

How much of the R&D drop was accounting versus cuts?

Expensed research and development fell by $1.14 million from last quarter while capitalized software rose by $0.73 million. Management should clarify how much total development spending actually fell and whether the lower expense rate will hold in the fourth quarter.

How much revenue did LailaCare and AI products bring in?

CareCloud booked its first enterprise AI workflow revenue from LailaCare this quarter, but did not give a dollar number. Without a separate figure for AI products, readers cannot tell if new tools are big enough to offset shrinking legacy software.

Why did unpaid customer bills jump while cash flow fell?

Accounts receivable rose $2.41 million in the quarter to $16.53 million, pulling free cash flow down 33.2% from a year ago despite record profit. Management should explain whether the jump came from slower customer payments or timing at new hospital clients.